Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin vs Tolterodine in Overactive Bladder
NCT00368706Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2006
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Sep 2006; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00368706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368706.